SEOUL, South Korea--(BUSINESS WIRE)--AB SCIEX, a global leader in life science analytical technologies, today announced that the company has expanded its commercial operations in Korea. The company created a new direct sales organization under AB SCIEX Korea to help customers located in Korea advance drug discovery, biomedical science, food and environmental safety testing, forensics and clinical research through the use of mass spectrometry technologies. This expansion was made possible by an agreement with Life Science Korea (LSK) to transfer existing sales, service and marketing personnel to AB SCIEX, effective immediately.
